Impact of KRAS mutational status on outcomes in patients with pancreatic cancer (PDAC).

被引：1
|
作者：
Ma, Lucy Xiaolu
Jang, Gun Ho
Zhang, Amy
Denroche, Robert Edward
Dodd, Anna
Ramotar, Stephanie
Hutchinson, Shawn
Wang, Yifan
Tehfe, Mustapha
Ramjeesingh, Ravi
Biagi, James Joseph
Lam, Bernard
Wilson, Julie
Notta, Faiyaz
Fischer, Sandra
Grant, Robert C.
Zogopoulos, George
Gallinger, Steven
Knox, Jennifer J.
O'Kane, Grainne M.
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Ontario Inst Canc Res, Toronto, ON, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada
[5] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[6] Dalhousie Univ, Nova Scotia Canc Ctr, Halifax, NS, Canada
[7] Queens Univ, Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[8] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
[9] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[10] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4142
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of mutational status of KRAS in the care of patients with colorectal cancer metastasis
    Assenat, E.
    Ychou, M.
    [J]. BULLETIN DU CANCER, 2009, 96 : S41 - S46
  • [2] Impact of KRAS mutational status on clinical outcomes in patients receiving capecitabine based chemotherapy
    Yarom, Nirit
    Gresham, Gillian
    Boame, Nana
    Jonker, Derek J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [3] Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC).
    Mehdi, Maahum
    Kamgar, Mandana
    George, Ben
    Szabo, Aniko
    Annunzio, Kaitlin
    Taylor, Bradley W.
    Shreenivas, Aditya Varnam
    Chakrabarti, Sakti
    Thomas, James P.
    Tsai, Susan
    Christians, Kathleen K.
    Evans, Douglas B.
    Clarke, Callisia
    Hall, William Adrian
    Erickson, Beth
    Ahmed, Gulrayz
    Thapa, Bicky
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] KRAS co-mutational landscape dictates treatment outcomes in pancreatic cancer (PC) patients
    Ghosh, Pritha
    George, Rohini
    Singh, Neeraj
    Agrawal, Smita
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [5] Impact of KRAS mutations on clinical outcomes in advanced refractory pancreatic cancer patients
    Sauri, T.
    Macarulla, T.
    Sanz-Garcia, E.
    Moreno, D.
    Vilaro, M.
    Vivancos, A.
    Elez, E.
    Argiles, G.
    Grasselli, J.
    Capdevila, J.
    Alsina, M.
    Hierro, C.
    Matos, I.
    Dientsmann, R.
    Nuciforo, P.
    Tabernero, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S470 - S470
  • [6] Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer
    Schlick, Konstantin
    Markus, Steiner
    Huemer, Florian
    Ratzinger, Lukas
    Zaborsky, Nadja
    Clemens, Hufnagl
    Neureiter, Daniel
    Neumayer, Bettina
    Beate, Alinger-Scharinger
    Florian, Steiner
    Martin, Varga
    Grundbichler, Michael
    Weiss, Lukas
    Melchardt, Thomas
    Greil, Richard
    Egle, Alexander
    [J]. PANCREATOLOGY, 2021, 21 (08) : 1466 - 1471
  • [7] KRAS and BRAF mutational status in colon cancer from Albanian patients
    Memeo, L.
    Costanzo, R.
    Martinetti, D.
    Kadare, S.
    Alimehmeti, M.
    Colarossi, C.
    Canzonieri, V.
    [J]. VIRCHOWS ARCHIV, 2013, 463 (02) : 316 - 316
  • [8] KRAS and BRAF mutational status in colon cancer from Albanian patients
    Martinetti, Daniela
    Costanzo, Rosario
    Kadare, Shahin
    Alimehmeti, Mehdiu
    Colarossi, Cristina
    Canzonieri, Vincenzo
    Berretta, Massimiliano
    Memeo, Lorenzo
    [J]. DIAGNOSTIC PATHOLOGY, 2014, 9
  • [9] KRAS and BRAF mutational status in colon cancer from Albanian patients
    Daniela Martinetti
    Rosario Costanzo
    Shahin Kadare
    Mehdiu Alimehmeti
    Cristina Colarossi
    Vincenzo Canzonieri
    Massimiliano Berretta
    Lorenzo Memeo
    [J]. Diagnostic Pathology, 9
  • [10] Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Norton, Carter
    Smith, Jarrod
    Rubnitz, Zach
    Tan, Grace H.
    Nevala-Plagemann, Christopher Duane
    Soares, Heloisa P.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 619 - 619
12345